REQUEST A DEMO
Total
USD $0.00
Search more companies

Investigacion y Desarrollo Pharmaceutico S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Investigacion y Desarrollo Pharmaceutico S.A.S Profile Updated: July 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Investigacion y Desarrollo Pharmaceutico S.A.S is an enterprise in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on June 09, 2020. It currently has a total number of 2 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 99.81% in 2024. Over the same period, its total assets grew by 44.58%. The net profit margin of Investigacion y Desarrollo Pharmaceutico S.A.S increased by 24.46% in 2024.

Headquarters
Cr 26 # 68 32 P 3
Bogota D.C.; Bogota D.C; Postal Code: 0217

Contact Details: Purchase the Investigacion y Desarrollo Pharmaceutico S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Investigacion y Desarrollo Pharmaceutico S.A.S report to view the information.
Financial Auditors:
Purchase the Investigacion y Desarrollo Pharmaceutico S.A.S report to view the information.
Incorporation Date:
June 09, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Investigacion y Desarrollo Pharmaceutico S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-99.81%
Total operating revenue
-99.81%
Operating profit (EBIT)
442.59%
Net Profit (Loss) for the Period
155.23%
Total assets
44.58%
Total equity
31.26%
Operating Profit Margin (ROS)
37.83%
Net Profit Margin
24.46%
Return on Equity (ROE)
7.48%
Quick Ratio
-2.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?